Results 201 to 210 of about 8,062,145 (231)

Integrated approaches to target nuclear receptors for managing the co-morbidity of tuberculosis and diabetes. [PDF]

Front Immunol
Arora R, Ahuja N, Kumawat S, Kaushal V, Sharma R, Gupta P.   +5 more
europepmc   +1 more source

WASP: a pipeline for functional annotation prediction based on AlphaFold structural models. [PDF]

Nat Commun
Del Missier G, Shabestary K, Ledesma-Amaro R.   +2 more
europepmc   +1 more source

Carbon starvation of <i>Mycobacterium abscessus</i> induces a non-replicating state with extensive proteomic remodeling. [PDF]

mSystems
Devlin KL, Lamichhane G, Nelson WC, Lin VS, Beatty KE.   +4 more
europepmc   +1 more source

Access in all areas? A round-up of developments in market access and health technology assessment: part 14. [PDF]

J Comp Eff Res
Ramagopalan SV, Pannelay AJ.
europepmc   +1 more source

International Union of Basic and Clinical Pharmacology. CXXII. Applying an objective evaluation to the status of class A orphan G protein-coupled receptors. [PDF]

Pharmacol Rev
Alexander SPH, Bennett KA, Brown AJ, Glass M, Gloriam DE, Hanson J, Insel PA, Kelly E, Langmead CJ, Martemyanov KA, Neubig RR, Offermanns S, Rosenkilde MM, Schulte G, Smith NJ, Wu H, Faccenda E, Harding SD, Davenport AP.   +18 more
europepmc   +1 more source

G Protein-Coupled Receptors in Prostate Cancer: Pathophysiological Implications and Potential for Innovative Therapeutics. [PDF]

Int J Mol Sci
Sarmento-Cabral A, Herrero-Aguayo V, Sáez-Martínez P, Alors-Pérez E, León-González AJ, López-Cánovas JL, Montero-Hidalgo AJ, Gahete MD, Jiménez-Vacas JM, Luque RM.   +9 more
europepmc   +1 more source

The Italian Assessment System for Innovative Medicines: An 8-Year Retrospective Analysis of Outcomes, Criteria, Timelines and Funding Dynamics. [PDF]

Appl Health Econ Health Policy
Martellone L, Servidio C, Vaccaro M, Malandrini K, Coluccia A, Oliva A, Mastroianni CM, Polito G.   +7 more
europepmc   +1 more source

Underutilised Crops for a Sustainable Future: Promoting Resilience and Nutrition in Global Food Systems. [PDF]

Physiol Plant
Moreira D, Santos C, da Silva MN, Pinto E, Knez M, Iannetta P, Tran F, Czeglédi A, Bassignana CF, Migliorini P, Landschoot S, Dewitte K, Haesaert G, Mattas K, Chiffoleau Y, Vasconcelos MW.   +15 more
europepmc   +1 more source

Trends, lag and characteristics of rare disease drug approval in the USA and China, 1983-2022. [PDF]

Orphanet J Rare Dis
Wang S, Liu X, Zou Y, Tang Y, Zuo W, Jiang R, Shang J, Tian X, Liu Q, Xu T, Zhang B, Zhang S.   +11 more
europepmc   +1 more source